Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma

MLA

Qiang Guo, et al. “Downregulation of T-Cell Cytotoxic Marker IL18R1 Promotes Cancer Proliferation and Migration and Is Associated with Dismal Prognosis and Immunity in Lung Squamous Cell Carcinoma.” Frontiers in Immunology, vol. 13, Dec. 2022. EBSCOhost, https://doi.org/10.3389/fimmu.2022.986447.

APA

Qiang Guo, Chuang-Yan Wu, Ni Jiang, Song Tong, Jun-Hao Wan, Xiao-Yue Xiao, Pei-Yuan Mei, Hua-Song Liu, & Si-Hua Wang. (2022). Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.986447

Chicago

Qiang Guo, Chuang-Yan Wu, Ni Jiang, Song Tong, Jun-Hao Wan, Xiao-Yue Xiao, Pei-Yuan Mei, Hua-Song Liu, and Si-Hua Wang. 2022. “Downregulation of T-Cell Cytotoxic Marker IL18R1 Promotes Cancer Proliferation and Migration and Is Associated with Dismal Prognosis and Immunity in Lung Squamous Cell Carcinoma.” Frontiers in Immunology 13 (December). doi:10.3389/fimmu.2022.986447.